Desflurane preconditioning induces time-dependent activation of protein kinase C epsilon and extracellular signal-regulated kinase 1 and 2 in the rat heart in vivo

Anesthesiology

Volumn 101, Issue 6, 2004, Pages 1372-1380

  Toma, Octavian ^a   Weber, Nina C ^a   Wolter, Jessica I ^a   Obal, Detlef ^a   Preckel, Benedikt ^a   Schlack, Wolfgang ^a,b  

^a Department of Anesthesiology ^*  (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CALPHOSTIN C; DESFLURANE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN KINASE C EPSILON; PROTEIN KINASE C INHIBITOR; SODIUM CHLORIDE; TRIPHENYLTETRAZOLIUM;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; EXCISION; HEART; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; IN VIVO STUDY; LUNG ALVEOLUS; MALE; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RAT STRAIN; STAINING; WESTERN BLOTTING;

EID: 9444289305     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200412000-00018     Document Type: Article

References (43)

1. Kersten JR, Schmeling TJ, Pagel PS, Gross GJ, Warltier DC: Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: Reduction of myocardial infarct size with an acute memory phase. ANESTHESIOLOGY 1997; 87:361-70
2. Cason BA, Gamperl AK, Slocum RE, Hickey RF: Anesthetic-induced preconditioning: Previous administration of isoflurane decreases myocardial infarct size in rabbits. ANESTHESIOLOGY 1997; 87:1182-90
3. Zaugg M, Lucchinetti E, Spahn DR, Pasch T, Schaub MC: Volatile anesthetics mimic cardiac preconditioning by priming the activation of mitochondrial K(ATP) channels via multiple signaling pathways. ANESTHESIOLOGY 2002; 97:4-14
4. Novalija E, Kevin LG, Camara AK, Bosnjak ZJ, Kampine JP, Stowe DF: Reactive oxygen species precede the epsilon isoform of protein kinase C in the anesthetic preconditioning signaling cascade. ANESTHESIOLOGY 2003; 99:421-8
5. Uecker M, Da Silva R, Grampp T, Pasch T, Schaub MC, Zaugg M: Translocation of protein kinase C isoforms to subcellular targets in ischemic and anesthetic preconditioning. ANESTHESIOLOGY 2003; 99:138-47
6. Bouwman RA, Musters RJ, Beek-Harmsen BJ, de Lange JJ, Boer C: Reactive oxygen species precede protein kinase C-delta activation independent of adenosine triphosphate-sensitive mitochondrial channel opening in sevoflurane-induced cardioprotection. ANESTHESIOLOGY 2004; 100:506-14
7. Ludwig LM, Weihrauch D, Kersten JR, Pagel PS, Warltier DC: Protein kinase C translocation and Src protein tyrosine kinase activation mediate isoflurane-induced preconditioning in vivo: potential downstream targets of mitochondrial adenosine triphosphate-sensitive potassium channels and reactive oxygen species. ANESTHESIOLOGY 2004; 100:532-9
8. Baines CP, Zhang J, Wang GW, Zheng YT, Xiu JX, Cardwell EM, Bolli R, Ping P: Mitochondrial PKC-ε and MAPK form signaling modules in the murine heart: Enhanced mitochondrial PKC-ε-MAPK interactions and differential MAPK activation in PKC-ε-induced cardioprotection. Circ Res 2002; 90:390-7
9. Fryer RM, Hsu AK, Gross GJ: ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection. Basic Res Cardiol 2001; 96:136-42
10. Abe J, Baines CP, Berk BC: Role of mitogen-activated protein kinases in ischemia and reperfusion injury: The good and the bad. Circ Res 2000; 86:607-9
11. Ping P, Zhang J, Cao X, Li RC, Kong D, Tang XL, Qiu Y, Manchikalapudi S, Auchampach JA, Black RG, Bolli R: PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. Am J Physiol 1999; 276:H1468-81
12. Da Silva R, Grampp T, Pasch T, Schaub MC, Zaugg M: Differential activation of mitogen-activated protein kinases in ischemic and anesthetic preconditioning. ANESTHESIOLOGY 2004; 100:59-69
13. Otani H, Okada T, Fujiwara H, Uchiyama T, Sumida T, Kido M, Imamura H: Combined pharmacological preconditioning with a G-protein-coupled receptor agonist, a mitochondrial KATP channel opener and a nitric oxide donor mimics ischaemic preconditioning. Clin Exp Pharmacol Physiol 2003; 30:684-93
14. Obal D, Preckel B, Scharbatke H, Mullenheim J, Hoterkes F, Thamer V, Schlack W: One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo. Br J Anaesth 2001; 87:905-11
15. Li Y, Kloner RA: Does protein kinase C play a role in ischemic preconditioning in rat hearts? Am J Physiol 1995; 268:H426-31
16. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR: PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 1995; 270:27489-94
17. Pang L, Sawada T, Decker SJ, Saltiel AR: Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 1995; 270:13585-8
18. Gong D, Fang Z, Ionescu P, Laster MJ, Terrell RC, Eger EI II: Rat strain minimally influences anesthetic and convulsant requirements of inhaled compounds in rats. Anesth Analg 1998; 87:963-6
19. Lowry OH: Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193:265-70
20. Zaugg M, Lucchinetti E, Uecker M, Pasch T, Schaub MC: Anaesthetics and cardiac preconditioning: Part I. Signalling and cytoprotective mechanisms. Br J Anaesth 2003; 91:551-65
21. Toma O, Weber NC, Obal D, Preckel B, Schlack W: Xenon induces myocardial protection by preconditioning: Involvement of protein kinase C (PKC). ANESTHESIOLOGY 2003; 99:A1540
22. Newton AC: Protein kinase C: Structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem Rev 2001; 101: 2353-64
23. Parekh DB, Ziegler W, Parker PJ: Multiple pathways control protein kinase C phosphorylation. EMBO J 2000; 19:496-503
24. Riess ML, Camara AK, Chen Q, Novalija E, Rhodes SS, Stowe DF: Altered NADH and improved function by anesthetic and ischemic preconditioning in guinea pig intact hearts. Am J Physiol 2002; 283:H53-H60
25. Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR: Is isoflurane-induced preconditioning dose related? ANESTHESIOLOGY 2002; 96:675-80
26. Riess ML, Kevin LG, Camara AK, Heisner JS, Stowe DF: Dual exposure to sevoflurane improves anesthetic preconditioning in intact hearts. ANESTHESIOLOGY 2004; 100:569-74
27. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R, Hewett TE, Jones SP, Lefer DJ, Peng CF, Kitsis RN, Molkentin JD: The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 2000; 19:6341-50
28. Yue TL, Wang C, Gu JL, Ma XL, Kumar S, Lee JC, Feuerstein GZ, Thomas H, Maleeff B, Ohlstein EH: Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res 2000; 86:692-9
29. Fryer RM, Pratt PF, Hsu AK, Gross GJ: Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther 2001; 296:642-9
30. Su JY, Vo AC: Role of protein kinase C, Ca2+/calmodulin-dependent protein kinase II, and mitogen-activated protein kinases in volatile anesthetic-induced relaxation in newborn rabbit pulmonary artery. ANESTHESIOLOGY 2003; 99:131-7
31. Zhong L, Su JY: Isoflurane activates PKC and Ca(2+) -calmodulin-dependent protein kinase II via MAP kinase signaling in cultured vascular smooth muscle cells. ANESTHESIOLOGY 2002; 96:148-54
32. Della Rocca GJ, van Biesen T, Daaka Y, Luttrell DK, Luttrell LM, Lefkowitz RJ: Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors: Convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, pyk2, and Src kinase. J Biol Chem 1997; 272:19125-32
33. Marais E, Genade S, Strijdom H, Moolman JA, Lochner A: p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning. J Mol Cell Cardiol 2001; 33:2157-77
34. Frances C, Nazeyrollas P, Prevost A, Moreau F, Pisani J, Davani S, Kantelip JP, Millart H: Role of beta 1- and beta 2-adrenoceptor subtypes in preconditioning against myocardial dysfunction after ischemia and reperfusion. J Cardiovasc Pharmacol 2003; 41:396-405
35. Hanouz JL, Yvon A, Massetti M, Lepage O, Babatasi G, Khayat A, Bricard H, Gerard JL: Mechanisms of desflurane-induced preconditioning in isolated human right atria in vitro. ANESTHESIOLOGY 2002; 97:33-41
36. Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Tanaka M, Shiojima I, Hiroi Y, Yazaki Y: Osidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest 1997; 100:1813-21
37. Mullenheim J, Ebel D, Frassdorf J, Preckel B, Thamer V, Schlack W: Isoflurane preconditions myocardium against infarction via release of free radicals. ANESTHESIOLOGY 2002; 96:934-40
38. Tanaka K, Weihrauch D, Ludwig LM, Kersten JR, Pagel PS, Warltier DC: Mitochondrial adenosine triphosphate-regulated potassium channel opening acts as a trigger for isoflurane-induced preconditioning by generating reactive oxygen species. ANESTHESIOLOGY 2003; 98:935-43
39. Mullenheim J, Frassdorf J, Preckel B, Thamer V, Schlack W: Ketamine, but not S(+)-ketamine, blocks ischemic preconditioning in rabbit hearts in vivo. ANESTHESIOLOGY 2001; 94:630-6
40. Molojavyi A, Preckel B, Comfere T, Mullenheim J, Thamer V, Schlack W: Effects of ketamine and its isomers on ischemic preconditioning in the isolated rat heart. ANESTHESIOLOGY 2001; 94:623-9
41. Herbert JM, Augereau JM, Gleye J, Maffrand JP: Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1990; 172:993-9
42. Kobayashi E, Nakano H, Morimoto M, Tamaoki T: Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1989; 159:548-53
43. Chen CL, Tai HL, Zhu DM, Uckun FM: Pharmacokinetic features and metabolism of calphostin C, a naturally occurring perylenequinone with antileukemic activity. Pharm Res 1999; 16:1003-9